Effect of overall treatment time on outcomes after concurrent chemoradiation for locally advanced non–small-cell lung carcinoma: Analysis of the Radiation Therapy Oncology Group (RTOG) experience

Author:

Machtay Mitchell,Hsu Chuanchieh,Komaki Ritsuko,Sause William T.,Swann R. Suzanne,Langer Corey J.,Byhardt Roger W.,Curran Walter J.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference22 articles.

1. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer;Furuse;J Clin Oncol,1999

2. Phase III comparison of sequential vs. concurrent chemoradiation for pts. with unresected stage III non-small cell lung cancer (NSCLC);Curran,2000

3. A randomized phase III trial of sequential chemo-radiotherapy versus concurrent chemo-radiotherapy in locally advanced non small cell lung cancer (NSCLC);Fournel;Proc Am Soc Clin Oncol,2001

4. Interfraction interval does not affect survival of patients with non–small-cell lung cancer treated with chemotherapy and/or hyperfractionated radiotherapy;Werner-Wasik;Int J Radiat Oncol Biol Phys,1999

5. The hazard of accelerated tumor clonogen repopulation during radiotherapy;Withers;Acta Oncol,1988

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3